Skip to content

Milk Against Respiratory Tract Infections and Asthma

Milk Against Respiratory Tract Infections and Asthma - MARTHA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00014781
Enrollment
960
Registered
2018-10-01
Start date
2018-11-07
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J45 J06 T78.4

Interventions

Group 1: Test milk
mildly pasteurized, not further processed cow's milk
from 6 to 9 months: daily 200ml milk
from 10 to 35 months: twice daily 150ml milk Group 2: Regularly processed cow's milk
from 10 to 35 months: twice daily 150ml milk

Sponsors

Klinikum der Universität München - Dr. von Haunersches Kinderspital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Months to 12 Months

Inclusion criteria

Inclusion criteria: Healthy, term-born (35 gestational weeks) infants of both sexes; Age 6 to 12 months at randomization; Caregivers with the ability to follow study instructions and likely to attend and complete all required visits; Caregivers have a mobile phone or a personal computer and are likely to keep a web-based diary regularly; Written informed consent of the parents or guardians

Exclusion criteria

Exclusion criteria: Suspected or confirmed cow’s milk allergy, milk intolerance, lactose intolerance, suspected immunodeficiency, cystic fibrosis, failure to thrive; Simultaneous participation in another intervention study; Maternal age below 18 years; Uncertainty of the study physician about prospective adherence to study protocol, e.g. known or persistent abuse of medication, drugs or alcohol in caregivers; A sibling already enrolled

Design outcomes

Primary

MeasureTime frame
Atopic sensitization at age 3 years

Secondary

MeasureTime frame
Physician diagnosis of asthma until age 5; Rhinitis irrespective of cough and wheeze until age 3 years; Respiratory tract infections without wheeze until age 3 years; Otitis media until age 3 years; Atopic eczema at age 3 years; Levels of high-sensitivity C-reactive protein in serum at age 3 years

Countries

Germany

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Jun 9, 2026